Minimal immunological changes in structurally malformed rats after prenatal exposure to cyclophosphamide

Area of Science:

• Developmental toxicology
• Immunotoxicology
• Teratology

Background:

• Cyclophosphamide (CP) is an immunosuppressive cytostatic agent with known teratogenic potential.
• Assessing the comparative sensitivity of morphological and immunological endpoints in teratology studies is crucial for risk assessment.

Purpose of the Study:

• To compare the sensitivity of morphological and immunological parameters in detecting effects of cyclophosphamide (CP) exposure during rat gestation.
• To evaluate the impact of CP on fetal development and immune system function at day 20 of gestation.

Main Methods:

• Pregnant rats were exposed to cyclophosphamide (CP) on gestation days 11 or 15.
• Teratological assessment included external and skeletal morphology evaluations.
• Histology, immunohistochemistry, flow cytometry, and a Trichinella spiralis infection model were used to assess immune function in fetal thymus, liver, and spleen.

Main Results:

• CP exposure induced dose-dependent gross morphological malformations and skeletal anomalies (e.g., brachygnathia, wavy ribs, lordosis).
• Immunological parameters, including immune cell analysis and function assays, showed only minimal differences between CP-treated and control groups.
• No significant impact on the immune system was detected despite observable teratogenic effects.

Conclusions:

• Morphological parameters are more sensitive than the immunological parameters tested in detecting the effects of cyclophosphamide (CP) exposure in this teratology study.
• The fetal immune system may exhibit remarkable recovery or inherent resistance to cyclophosphamide (CP) following in utero exposure.